Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
ACS Nano|November 12, 2009
Organic light-emitting diodes on solution-processed graphene transparent electrodesJunbo Wu, Mukul Agrawal, Héctor A Becerril, et al.
Disease Markers|January 31, 2020
Clinical and Prognostic Implications of P21 (WAF1/CIP1) Expression in Patients with Esophageal Cancer: A Systematic Review and Meta-AnalysisJunbo Wu, Liang Liu, Feng Wu, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 1, 2025
Prediction of Occult Peritoneal Metastasis of Gastric Cancer Based on CT-Based Body Fat AnalysisKangjia Du, Li Ma, Yongai Li, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 26, 2025
Direct Visualization of Lipid Raft Domains in Plasma Membranes via Cryo-Electron Tomography and In Situ Gold Nanoparticle LabelingYaxuan Zhang, Sihang Cheng, Junbo Wu, et al.
Frontiers in Pharmacology|December 15, 2022
From tryptamine to the discovery of efficient multi-target directed ligands against cholinesterase-associated neurodegenerative disordersJunbo Wu, Honghua Zhang, Yuying Wang, et al.
American Journal of Cancer Research|April 14, 2025
Prognostic significance of systemic inflammatory response markers NLR, PLR, and MLR in advanced high-risk endometrial cancer following radiotherapyLiang Ma, Yumeng Zhang, Yuheng Shao, et al.
International Journal of Biological Macromolecules|February 18, 2026
Design a multi-epitope vaccine targeting Chlamydia psittaci plasmid proteins through reverse vaccinologyLinglan Xu, Mingxing Liang, Zhixi Chen, et al.
Plos One|March 28, 2025
Integrated analysis and single-cell sequencing of mitochondrial metabolism related gene molecular subtype and diagnostic model in ulcerative colitisLi Li, Xiaoyao Chen, Tao Li, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 22, 2012
Identification of the PAG1 gene as a novel target of inherent radioresistance in human laryngeal carcinoma cellsQing Ke, Junbo Wu, Bangchun Ming, et al.
European Journal of Medicinal Chemistry|January 3, 2024
Structure-activity relationship study of 1,6-naphthyridinone derivatives as selective type II AXL inhibitors with potent antitumor efficacyLinsheng Zhuo, Mengqin Guo, Siyi Zhang, et al.
Pageof 4